A Study of Local Therapy for the Treatment of Brain Metastases From HER2 Positive Breast Cancer

NACompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

November 20, 2017

Primary Completion Date

July 22, 2021

Study Completion Date

December 31, 2021

Conditions
Breast Neoplasms
Interventions
OTHER

Local Therapy

"Neurosurgery: The decision whether or not to recommend neurosurgery will be made independently of this research study. The complexity and length of the surgery depends on the size and location of the tumour(s).~Stereotactic Radiosurgery: If the participant will be receiving stereotactic radiosurgery (either alone or in combination with neurosurgery), the Radiation Oncologist will organise for the participant to have a Radiotherapy planning. Single metastasis, smaller than or equal to 2cm, may require 1 fraction. Alternately, multiple metastasis, metastasis in the brain stem, or those bigger than 2cm will required multiple fractions to treat. The dose range for the study is 20Gy/1 fraction to 24Gy/3 fractions."

Trial Locations (1)

3000

Peter MacCallum Cancer Centre, Melbourne

All Listed Sponsors
lead

Trans Tasman Radiation Oncology Group

OTHER

NCT02898727 - A Study of Local Therapy for the Treatment of Brain Metastases From HER2 Positive Breast Cancer | Biotech Hunter | Biotech Hunter